ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Clinical trials for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROTIC CARDIOVASCULAR DISEASE trials appear
Sign up with your email to follow new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug HRS9531 aims to prevent heart attacks in 9,000+ patients
Disease control Not yet recruitingThis study tests if a new medicine, HRS9531, can lower the chance of major heart problems like heart attacks and strokes in people with hardened arteries. About 9,262 adults with heart disease will receive either the drug or a placebo. The goal is to see if the drug helps control…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Phase: PHASE3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Italian study to track Long-Term use of cholesterol drugs
Knowledge-focused Not yet recruitingThis study will follow nearly 6,000 adults in Italy who are prescribed inclisiran, evolocumab, or alirocumab for high cholesterol or heart disease. Researchers want to see how consistently patients take these medications over time in everyday practice. The goal is to understand r…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 01:59 UTC